GWF-31779-74046 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2021-02-04
Registered in v-safe
2021-02-04
Dose 1 — Pfizer-BioNTech
2021-02-04
Survey response — day 0, dose 1
MedDRA: Respiratory tract congestion, Upper-airway cough syndrome — Feeling: Good · Site: Pain, Swelling, Itching · Fever · Headache, Muscle or body aches

Free text: Post nasal drip, mild congestion

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-02-05
Health check-in — days 1–6 daily, dose 1
Feeling: Fair · Site: Pain, Redness, Itching · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Rash, not including the immediate area around the injection site · Be unable to do your normal daily activities

Adult check-in
2021-02-06
Health check-in — days 1–6 daily, dose 1
Feeling: Fair · Site: Pain, Itching · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Rash, not including the immediate area around the injection site

Adult check-in
2021-02-08
Health check-in — days 1–6 daily, dose 1
Feeling: Good · Fatigue or tiredness

Adult check-in
2021-02-11
Health check-in — day 7, dose 1
Feeling: Good · Joint pains, Muscle or body aches

Adult check-in
2022-02-06
Survey response — 12 months, dose 1
MedDRA: Abortion spontaneous, Illness, Pollakiuria, Urinary tract infection — Feeling: Fair · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visit, Hospitalization

Free text: Miscarriages, significant increase in sicknesses, urinary frequency, frequent UTIs

MedDRA releases: 2024-11 · check-in free text available
2022-02-06
Report sent to call center — 12 months, dose 1
Get care from a doctor or other healthcare professional

Telehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · Hospitalization · 1 call case(s)
2022-02-08
Call 1 — Left Voicemail

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2021-02-04	Pfizer-BioNTech

Call center

Reported	Outcome	VAERS-related outcome
2022-02-06	Unsuccessful

Free text

Release 3 — day 0, dose 1

2021-02-04

Systemic reaction (other): Post nasal drip, mild congestion

Release 11 — 12 months, dose 1

2022-02-06

Symptoms: Miscarriages, significant increase in sicknesses, urinary frequency, frequent UTIs

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	Abortion spontaneous	·	·	✓
SD	Illness	·	·	✓
SD	Pollakiuria	·	·	✓
SD	Urinary tract infection	·	·	✓
SRO	Respiratory tract congestion	✓	✓	✓
SRO	Upper-airway cough syndrome	✓	✓	✓

✓ active code · ○ coded but marked inactive · blank = not in that release